Ductal carcinoma in situ refers to the cells that arise in the ducts of the breast that are malignant in their own right. In other words, if you were to look at them under a microscope, you could ...

Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, accounts for 1 of every 5 new breast cancer diagnoses. It's an uncontrolled growth of cells within the breast ducts.

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

What is ductal carcinoma in situ? DCIS is a noninvasive form of breast cancer that affects the cells of the milk ducts. DCIS accounts for about 20% to 25% of US breast cancer diagnoses.

Risk of progression differs in high risk and low risk cases when surgery is omitted Ductal carcinoma in situ (DCIS) is a non-obligate precursor lesion of invasive breast cancer. Since the ...

Ductal carcinoma in situ lies along a spectrum of preinvasive lesions originating within normal breast tissue, with histologic progression from atypical hyperplasia to invasive breast cancer (). 1 ...

Carcinoma in situ, or stage 0 cancer, refers to precancerous cells in a limited area. It is not cancer and may not become malignant. Learn more.

Specifically, ductal carcinoma in situ. Dr. Nina Tamirisa is with the department of Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.

Ductal carcinoma in situ: to treat or not to treat, that is the question M V Seijen and others British Journal of Cancer, August 2019. Volume 121, Issue 4, Pages 285 to 292. Breast cancer in situ E R ...

Ductal carcinoma in situ (DCIS) is a heterogeneous group of diseases that differ in biology and clinical behavior. Until 1980, DCIS represented less than 1% of all breast cancer cases. With the ...

Actor Danielle Fishel, 43, from Arizona said on her podcast that she had ductal carcinoma in situ, or DCIS, a type of breast cancer that affects the milk ducts.